Asset icon - trade crypto, stocks, and gold on Pluang
Trade on Pluang
One platform for all markets
Download
icon
icon
Us company
Asset icon - trade crypto, stocks, and gold on Pluang

Buy & Sell BIO-TECHNE Corp (TECH) – BIO-TECHNE Corp Price Today

24H
1W
1M
3M
YTD
1Y
5Y

Aura AI Summary

Bio-Techne Corporation (TECH) trades at $48.21, up 1.8% with a bearish technical outlook despite strong analyst support. The company reported mixed Q3 2026 results with an earnings miss but maintains solid gross margins of 64.96%. Recent news highlights academic funding challenges affecting revenue, though management remains active in investor conferences. Valuation metrics appear elevated with P/E of 68.89 and P/S of 6.25, while cash flow trends show improvement in 2026 projections.
The stock faces near-term pressure from earnings volatility and high valuations, but analyst consensus remains bullish with a $61 price target representing 27% upside. Key risks include academic funding dependency and competitive pressures, while institutional ownership stability and dividend payments provide support. The upcoming Q2 2026 earnings on May 19th will be critical for confirming the company's growth trajectory.
Read full analysis

Key Stats

  • Market Cap
    $7.55B
  • Sector
    Health
  • 3M Drawdown
    -28.51%
  • Enterprise Value
    $7.63B
  • Dividend Yield
    0.66%
  • Typical Hold Time
    63 days
$48.21
52W Low: $43.31
15 May 2026
52W High: $71.38
21 Jan 2026

BIO-TECHNE Corp (TECH) is currently valued at a market capitalization of $7.55B, with an enterprise value of $7.63B. Over the past 52 weeks, BIO-TECHNE Corp has traded between a low of $43.31 and a high of $71.38, highlighting its annual price range. Over the past three months, BIO-TECHNE Corp has recorded a drawdown of -28.51%, reflecting recent price volatility. BIO-TECHNE Corp offers a dividend yield of 0.66%, with the most recent dividend of $0.08 paid on 18 May 26. On average, investors hold BIO-TECHNE Corp for approximately 63 days, indicating typical investor behavior on the platform.

About BIO-TECHNE Corp

Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. The company reports in two segments, protein sciences (75% of revenue), and diagnostics and genomics (25%). The protein-focused segment makes equipment and associated consumables for protein characterization and analysis and sells antibodies for research and clinical purposes. In diagnostics, Bio-Techne provides controls and calibrators for diagnostic manufacturers and has a portfolio of diagnostic oncology assays. The United States accounts for about 55% of revenue, and the firm also has operations in EMEA (20% of sales), the U.K. (5%), and APAC (15%), with the rest of the world accounting for the remaining 5%.



People also bought


Global US Market Prices


Frequently Asked Questions

US stocks trading hours: Monday - Friday (Except for US public holidays) Time: 21.30 - 04.00 WIB 20.30 - 03.00 WIB (Daylight Savings Time*) *The next Daylight Savings is scheduled to begin on March 13, 2022 and ends on November 6, 2022. You can place limit orders outside of the trading hours, but it can only be executed during trading hours. For illustration, a stock is currently trading at $10 per share, but you only want to pay $7 per share at most. Let’s say you set your limit price to $7 at 18.00. Your order will be executed when the market is open at 21.30 if the stock drops from $10 to $7 or lower. Similarly, if the stock price doesn’t drop to $7, your order won’t be executed.
Yes, you are eligible to receive dividend payment if and when the company pays them on one condition: minimum net dividend paid is at least $0.01. Net dividend is gross dividend subtracted by 15% withholding tax.
Yes, it is. US Stocks risk is managed by PT PG Berjangka which is licensed by Badan Pengawas Perdagangan Berjangka Komoditi (BAPPEBTI), and your investment is guaranteed by Jakarta Futures Exchange (JFX) and Indonesian Clearing House (KBI).
Pluang charges a fixed transaction fee of 0.30% for regular users and 0.20% for Pluang Plus members, including VAT to cover the exchange fees and operational costs.

Key Stats

  • Market Cap
    $7.55B
  • Sector
    Health
  • 3M Drawdown
    -28.51%
  • Enterprise Value
    $7.63B
  • Dividend Yield
    0.66%
  • Typical Hold Time
    63 days
$48.21
52W Low: $43.31
15 May 2026
52W High: $71.38
21 Jan 2026

BIO-TECHNE Corp (TECH) is currently valued at a market capitalization of $7.55B, with an enterprise value of $7.63B. Over the past 52 weeks, BIO-TECHNE Corp has traded between a low of $43.31 and a high of $71.38, highlighting its annual price range. Over the past three months, BIO-TECHNE Corp has recorded a drawdown of -28.51%, reflecting recent price volatility. BIO-TECHNE Corp offers a dividend yield of 0.66%, with the most recent dividend of $0.08 paid on 18 May 26. On average, investors hold BIO-TECHNE Corp for approximately 63 days, indicating typical investor behavior on the platform.

Let’s invest in this asset by signing up or download!